Fast Five Quiz: Breast Cancer Treatment

Patients in whom definitive surgery may be delayed would be appropriate candidates for preoperative systemic therapy. Other candidates would be:

Patients with inoperable breast cancer:

• Inflammatory breast cancer

• Bulky or matted cN2 axillary nodes

• cN3 nodal disease

• cT4 tumors

In patients with operable breast cancer, preoperative systemic therapy is preferred for:

• HER2-positive disease and triple-negative breast cancer, if cT ≥ 2 or cN ≥ 1

• Large primary tumor relative to breast size in a patient who desires breast conservation

• cN+ disease likely to become cN0 with preoperative systemic therapy

Learn more about the treatment of breast cancer.

Medscape © 2021 WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Pavani Chalasani. Fast Five Quiz: Breast Cancer Treatment - Medscape - Jul 12, 2021.